企業プロフィール

Certara 株価・ニュース・カタリスト

ティッカー:
CERT
取引所:
NASDAQ
セクター:
Biopharma
所在地:
United States

株価パフォーマンス

8.00 USD (0.00%)

終値

最終更新: 2026年8月17日

874M USD

時価総額

株価変動の要因

As of Aug 17, 2026, CERT was little changed and closed at $8.00. No new same-company headline was identified in the current news window.

企業概要

Model-Informed Drug Development

Certara provides biosimulation software and technology-enabled services used throughout drug discovery, clinical development and regulatory review. Its tools help predict how medicines behave in different patients and dosing scenarios.

Software Portfolio

The company's software includes pharmacokinetic, pharmacodynamic, quantitative-systems-pharmacology and clinical-trial simulation applications. Customers use these products to inform dose selection, study design and regulatory submissions. Certara serves pharmaceutical and biotechnology companies, academic institutions and regulators. Its business combines recurring software subscriptions with scientific consulting and implementation services.

今後のカタリスト

    最近のニュース

    1. 01
    2. 02
    3. 03
    4. 04
    5. 05

    類似銘柄

    事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。